2020年発表論文

2020.02.14

2020年に当教室で発表した和文原著です。

題名（論文名）	著者	掲載雑誌
下部尿路症状を伴う性腺機能低下症患者に対するタダラフィル5mg連日投与の付随効果－テストステロン・性機能・高感度C-reactive proteinに対する効果．	重原一慶，島村正喜，川口昌平，野原隆弘，泉浩二，角野佳史，庄田良中，溝上敦	泌尿紀要2020; 66(8):259-264.
【高齢者の安全な泌尿器科診療を目指して】(chapter 3)高齢者の泌尿器がん　高齢者に対する前立腺がんの治療戦略	岩本大旭，泉浩二，溝上敦	Uro-Lo: 泌尿器Care & Cure 2020; 25(2): 230-234.
前立腺腫瘍学の変遷からひもとく進行期前立腺癌治療に求めるもの　進行期前立腺癌の根治は目指せるか?　前立腺癌の治療とBone health.	溝上敦	西日本泌尿器科2020: 82(1); 32-36.
【前立腺癌治療の合併症・副作用マネージメント】ERA-223試験と前立腺癌治療におけるbone health．	溝上敦．	Prostate Journal 2020; 7(1): 71-75.
前立腺がんの放射線療法　薬物療法　ロボット手術　最新情報をお伝えします】(chapter 2)前立腺がんのtreatment　進行性(転移のある)前立腺がんの放射線療法.	牧野友幸, 溝上敦	Uro-Lo: 泌尿器Care & Cure 2020; 25(3): 363-370.
【性ホルモンと産生・依存性腫瘍の基礎と臨床】性ホルモン依存性悪性腫瘍　進行前立腺癌におけるホルモン療法の変遷と最近のTopics.	八重樫洋，泉浩二，溝上敦．	HORMONE FRONTIER IN GYNECOLOGY 2020: 27(2): 43-48.
高リスク転移性ホルモン療法感受性前立腺癌患者の臨床転帰を観察するレジストリ試験.	松山豪泰, 溝上敦, 鈴木蘭美.	泌尿器外科2020 ; 33(4); 315-317.
日本人男性不妊患者の尿および精液検体からのHPV, Mycoplasma, Ureaplasma検出についての検討	加藤佑樹，重原一慶，中野泰斗，中川朋美，岩本大旭，八重樫洋，飯島将司，中嶋一史，川口昌平，野原隆弘，泉浩二，角野佳史，溝上敦	日性感染症学会誌 2020; doi:10.24775/jjsti.O-2020-0001.
前立腺癌oligometastasesに対する放射線照射の有効性に関する検討.	八重樫洋, 門本卓, 内藤伶奈人, 牧野友幸, 岩本大旭, 飯島将司, 川口昌平, 野原隆弘, 重原一慶, 泉浩二, 角野佳史, 櫻井孝之, 高松繁行, 熊野智康, 水野英一, 溝上敦.	泌尿器外科2020; 33(8): 1065-1068.
女性の初尿検体と導尿検体におけるHPV検出についての検討.	川口昌平，重原一慶，大阪康宏，中川朋美，加藤佑樹，坂本次郎，中嶋一史，笹川寿之，溝上敦.	日性感染症会誌doi:10.24775/jjsti.O-2020-0009.
染色体・遺伝子異常と男性不妊症．	飯島将司．	月刊泌尿器科2020; 12(5): 540-545.
局所進行、オリゴメタ前立腺がんに対するHDR-brachytherapy.	牧野友幸，溝上敦	月刊泌尿器科2020; 11(4): 442-450.

2020年に当教室で発表し英文原著です（2020年に掲載予定のもの）。

題名（論文名）	著者	掲載雑誌
Testosterone Replacement Therapy for Patients with Hypogonadism after High Dose-Rate Brachytherapy for High-Risk Prostate Cancer: A Report of Six Cases and Literature Review.	Kadomoto S, Shigehara K, Iwamoto H, Yaegashi H, Izumi K, Kadono Y, Mizokami A.	World J Mens Health. 2020; 38(1):132-136.
The Five-Year Effects of Testosterone Replacement Therapy on Lipid Profile and Glucose Tolerance among Hypogonadal Men in Japan: A Case Control Study.	Kato Y, Shigehara K, Nakashima K, Iijima M,Kawagushi S, Nohara T, Izumi K, Kadono Y, Konaka H, Namiki M, Mizokami A.	Aging male. 2020; 23(1):23-28.
Y chromosome microdeletion screening using a new molecular diagnostic method in 1030 Japanese males with infertility.	Iijima M, Shigehara K, Igarashi H, Kyono K, Suzuki Y, Tsuji Y, Kobori Y, Kobayashi H, Mizokami A.	Asian J Androl. 2020; 22(4):368-371.
Comparison of Tolerability Between 2-Weekly and 3-Weekly Docetaxel Regimen in Castration-resistant Prostate Cancer.	Shimura Y, Suga Y, Itai S, Iwamoto H, Takezawa Y, Yaegashi H, Izumi K, Shimada T, Sai Y, Matsushita R, Mizokami A.	Anticancer Res. 2020 ;40(8):4291-4297.
Reply to Comment on “Kadomoto, S. et al. Tumor-Associated Macrophages Induce Migration of Renal Cell Carcinoma Cells via Activation of the CCL20-CCR6 Axis” Cancers 2020 12, 89.	Kadomoto S, Izumi K, Hiratsuka K, Nakano T, Naito R, Makino T, Iwamoto H, Yaegashi H, Shigehara K, Kadono Y, Nakata H, Saito Y, Nakagawa-Goto K, Mizokami A.	Cancers (Basel). 2020; 12(2):354
The Efficacy of Second-line Chemotherapy for Advanced or Metastatic Urothelial Cancer.	Naito R, Izumi K, Kadomoto S, Makino T, Iwamoto H, Yaegashi H, Shigehara K, Kadono Y, Mizokami A.	Anticancer Res. 2020;40(2):1141-1146.
Prevalence of N. gonorrhoeae, C. trachomatis, M. genitalium, M. hominis and Ureaplasma spp. in the anus and urine among Japanese HIV-infected men who have sex with men.	Kato Y, Kawaguchi S, Shigehara K, Yaegashi H, Nakashima K, Nakagawa T, Sakamoto J, Itoda I, Ueda M, Izumi K, Kadono Y, Mizokami A.	J Infect Chemother. 2020; 26(4):403-406.
A Randomized, Double-Blind, Comparison of radium-223 and Placebo, in Combination With Abiraterone Acetate and Prednisolone, in Castration-Resistant Metastatic Prostate Cancer: Subgroup Analysis of Japanese Patients in the ERA 223 Study.	Matsubara N, Kimura G, Uemura H, Uemura H, Nakamura M, Nagamori S, Mizokami A, Kikukawa H, Hosono M, Kinuya S, Krissel H, Siegel J, Kakehi Y.	Int J Clin Oncol. 2020; 25(4):720-731.
A Case Report of Chyloretroperitoneum Post Living-Donor Transplantation.	Kawaguchi S, Kadono Y, Nohara T, Kato Y, Nakagawa T, Urata S, Yaegashi H, Nakashima K, Iijima M, Shigehara K, Izumi K, Mizokami A.	Urol Int. 2020;104(1-2):160-162.
Recovery of serum testosterone following neoadjuvant androgen deprivation therapy in Japanese prostate cancer patients treated with low-dose rate brachytherapy	Kato Y, Shigehara K, Kawaguchi S, Izumi K, Kadono Y, Mizokami A.	Aging Male. 2020; Feb 25: 1-7.
Therapeutic Effect of Ethinylestradiol in Castration-resistant Prostate Cancer.	Nakano T, Kadono Y, Iwamoto H, Yaegashi H, Iijima M, Kawaguchi S, Nohara T, Shigehara K, Izumi K, Mizokami A.	Anticancer Res. 2020;40(4):2291-2296.
Human papillomavirus 16-positive penile Bowen’s disease with an invasion in the distal urethra: A case report.	Sakamoto J, Shigehara K, Shimizu K, Maeda S, Nakagawa T, Kawaguchi S, Izumi K, Kadono Y, Mizokami A.	SAGE Open Med Case Rep. 2020;8:2050313.
Atezolizumab With or Without Chemotherapy in Metastatic Urothelial Cancer (IMvigor130): A Multicentre, Randomised, Placebo-Controlled Phase 3 Trial. Lancet.	Galsky MD, Arija JÁA, Bamias A, Davis ID, De Santis M, Kikuchi E, Garcia-Del-Muro X, De Giorgi U, Mencinger M, Izumi K, Panni S, Gumus M, Özgüroğlu M, Kalebasty AR, Park SH, Alekseev B, Schutz FA, Li JR, Ye D, Vogelzang NJ, Bernhard S, Tayama D, Mariathasan S, Mecke A, Thåström A, Grande E; IMvigor130 Study Group.	Lancet. 2020;395(10236):1547-1557.
Prevalence, Genotype Distribution, and Predictors Against HPV Infections Targeted by 2-, 4-, 9-Valent HPV Vaccines Among Japanese Males.	Matsuzawa Y, Kitamura T, Suzuki M, Koyama Y, Shigehara K.	Vaccines (Basel). 2020; 8(2):E221.
The Impact of Hypertension on the Clinicopathological Outcome and Progression of Renal Cell Carcinoma.	Makino T, Izumi K, Iwamoto H, Kadomoto S, Naito R, Yaegashi H, Shigehara K, Kadono Y, Mizokami A.	Anticancer Res. 2020; 40(7):4087-4093.
A randomized, double-blind, comparison of radium-223 and placebo, in combination with abiraterone acetate and prednisolone, in castration-resistant metastatic prostate cancer: subgroup analysis of Japanese patients in the ERA 223 study.	Matsubara N, Kimura G, Uemura H, Uemura H, Nakamura M, Nagamori S, Mizokami A, Kikukawa H, Hosono M, Kinuya S, Krissel H, Siegel J, Kakehi Y.	Int J Clin Oncol. 2020; 25(4):720-731.
Efficacy of Testosterone Replacement Therapy on Pain in Hypogonadal Men with Chronic Pain Syndrome: A Subanalysis of a Prospective Randomized Controlled Study in Japan (EARTH Study).	Kato Y, Shigehara K, Kawaguchi S, Izumi K, Kadono Y, Mizokami A.	Andrologia 2020; 52(9): e13768.
Comparison of dutasteride efficacy among the patients with small versus large benign prostatic hypertrophy.	Shigehara K, Kato Y, Kawaguchi K, Izumi K, Kadono Y, Mizokami A.	Cur Urol. 2020 (in press).
First-line immune checkpoint inhibitors for patients with metastatic urothelial carcinoma treated in routine clinical practice.	Naito R, Izumi K, Mizokami A.	Transl Androl Urol. 2020; 9(3): 986–990.
The CCL20-CCR6 Axis in Cancer Progression.	Kadomoto S, Izumi K, Mizokami A.	Int J Mol Sci. 2020; 21(15):5186.
Is the C-C Motif Ligand 2-C-C Chemokine Receptor 2 Axis a Promising Target for Cancer Therapy and Diagnosis?	Iwamoto H, Izumi K, Mizokami A.	Int J Mol Sci. 2020; 21(23):9328.
Effects of Short-term Testosterone Replacement Therapy on the Risk Predictors for Arteriosclerosis among Men with Late-Onset Hypogonadism: A Case–Control Study.	Shigehara K, Izumi K, Kadono K, Namiki M, Mizokami A.	J Mens Health. 2020; 16(4):e65–e71.
Toxicity and clinical outcomes of single-fraction high-dose-rate brachytherapy combined with external beam radiotherapy for high-/very high-risk prostate cancer: A dosimetric analysis of toxicity.	Sakurai T, Takamatsu S, Shibata S, Iwata K, Taka M, Gabata T, Kumano T, Makino T, Mizokami A.	Jpn J Radiol. 2020 ;38(12):1197-1208.
Regenerative treatment for male stress urinary incontinence by periurethral injection of adipose-derived regenerative cells: Outcome of the ADRESU study.	Gotoh M, Shimizu S, Yamamoto T, Ishizuka O, Yamanishi T, Mizokami A, Narimoto K, Toriyama K, Kamei Y, Nakayama S, Kuwatsuka Y, Mizuno M, Hirakawa A.	Int J Urol. 2020; 27(10):859-865.
Efficacy and safety of keishibukuryogan, a traditional Japanese Kampo medicine, for hot flashes in prostate cancer patients receiving androgen deprivation.	Shigehara K, Izumi K, Nakashima K, Kawaguchi S, Nohara T, Kadono Y, Mizokami A.	Transl Urol Androl. 2020; 9(6):2533-2540.
A case of adrenal lymphangioma resected laparoscopically with minimal invasiveness.	Yaegashi H, Nohara T, Shigehara K, Izumi K, Kadono Y, Mizokami A.	Urol Case Rep. 2020;33:101400.

一覧に戻る